AbbVie wants to see shared decision making widely adopted across NHS services.
To support this ambition, throughout 2020 AbbVie worked to highlight
the importance of shared decision making. In Spring, we held the
Shared Decision Making Showcase in Parliament. A year on from the
publication of NHS England’s NHS Long Term Plan, and Universalised
Personalised Care Plan – which established ambitious targets to put
SDM at the heart of patient care – the showcase provided a platform
for patient groups, NHS Trusts, and healthcare providers to share
their innovative work.
The projects at the Showcase ranged from MS, arthritis, Lymphoma,
Autism, Hepatitis C, kidney dialysis and more — all focused on
empowering patients to take an active part in decisions about their
treatment and care.
As the year and the COVID-19 pandemic progressed, we wanted to delve
into how the virus has impacted patients, healthcare professionals and
the entire NHS system. In Autumn 2020, we held two virtual
discussions with patient advocacy groups, national and professional
bodies and key stakeholders to understand how the pandemic has
impacted SDM, as well as the longer term changes needed to improve
patient involvement in their treatment and care decisions as a whole.
These discussions brought to light both the existing challenges and
new opportunities to redesign and reshape our NHS to embed SDM as best